The effects of beta blockade on dopamine and dobutamine induced hypokalaemia in dogs
- PMID: 2600289
- DOI: 10.1007/BF00255601
The effects of beta blockade on dopamine and dobutamine induced hypokalaemia in dogs
Abstract
The effect of beta 1 and beta 2 blockade on dopamine and dobutamine induced hypokalaemia was investigated in dogs. Arterial plasma potassium was continuously monitored using a potassium-sensitive electrode sited in the abdominal aorta. Dopamine and dobutamine were infused at 15 micrograms kg-1 min-1 into animals pre-treated with atenolol (0.5 mg kg-1) or ICI 118551 (0.5 mg kg-1) and the potassium changes compared to those seen in control animals. The inotrope infusions caused a small and transient rise in plasma potassium (p less than 0.05) followed by a more profound hypokalaemia (p less than 0.05) sustained for the duration of the infusion. The potassium falls in the control animals were similar to those in the beta 1 and beta 2 blockade groups. The results suggest that beta 2 receptor stimulation cannot alone be responsible for dopamine and dobutamine induced hypokalaemia and a multiple receptor activation is postulated.
Similar articles
-
Continuous multi-channel intravascular monitoring of the effects of dopamine and dobutamine on plasma potassium in dogs.Intensive Care Med. 1989;15(7):446-51. doi: 10.1007/BF00255600. Intensive Care Med. 1989. PMID: 2600288
-
Dopamine and dobutamine induce hypokalemia in anesthetized dogs.J Cardiovasc Pharmacol. 1989 Apr;13(4):662-6. J Cardiovasc Pharmacol. 1989. PMID: 2471006
-
The selective effects of dopamine and dobutamine on liver circulation in the dog.J Vet Med Sci. 1995 Apr;57(2):293-7. doi: 10.1292/jvms.57.293. J Vet Med Sci. 1995. PMID: 7492649
-
Impact of dopamine or dobutamine infusions on cardiovascular variables after rapid blood loss and volume replacement during isoflurane-induced anesthesia in dogs.Am J Vet Res. 2006 Jul;67(7):1121-30. doi: 10.2460/ajvr.67.7.1121. Am J Vet Res. 2006. PMID: 16817731 Clinical Trial.
-
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):557-567. doi: 10.1093/ehjcvp/pvab038. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33956964 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous